НовостиBenzingaWedbush Initiates Coverage On Mentari Therapeutics with Outperform Rating, Announces Price Target of $33 Wedbush Initiates Coverage On Mentari Therapeutics with Outperform Rating, Announces Price Target of $33 Benzinga 2026.11.13 13:35 (GMT+0) Открыть на Benzinga Другие новости